Core Points - The United States District Court for the Eastern District of New York has approved a proposed class action settlement for purchasers of Mynaric AG American Depositary Shares (ADS) [1][2] - The settlement amount is $300,000, with an estimated average recovery of approximately $0.1370 per share for affected Mynaric ADS holders [2][3] Settlement Details - The settlement fund of $300,000 will be created by the Defendants and may accrue interest, to be distributed among eligible Settlement Class Members after deducting court-awarded fees and expenses [3] - A hearing is scheduled for September 16, 2025, to consider the fairness and adequacy of the settlement, the allocation plan, and the application for attorneys' fees [4] Participation and Exclusion - Settlement Class Members must submit a Claim Form by August 4, 2025, to be eligible for a distribution from the Net Settlement Fund [7] - Members wishing to exclude themselves from the Settlement Class must submit a written request by August 19, 2025 [8] Objections - Any objections to the proposed settlement or related applications must be filed with the Court by August 19, 2025 [9]

Core Insights - Mynaric has successfully delivered over 100 CONDOR Mk3 optical communications terminals, including a complete launch set for the Space Development Agency's Proliferated Warfighter Space Architecture program [2] - The company is advancing the development of the CONDOR Mk3.1 terminal, which aims to support higher data rates of up to 100 Gbps while improving efficiency and reducing weight and power consumption [2][3] - Mynaric's production capabilities have ramped up, achieving triple-digit yields in the first half of the year despite earlier delays due to supplier shortages [3] Company Developments - Mynaric is focused on enhancing profitability and ensuring long-term financial stability following the confirmation of its restructuring plan [4] - The company has manufactured over 150 optical heads for the CONDOR Mk3 terminal, indicating a strong production capacity [3] - Mynaric's approach emphasizes collaboration with customers to meet evolving mission requirements and market needs [3] Industry Context - Mynaric is positioned as a leader in the industrial revolution of laser communications, providing solutions for air, space, and mobile applications [5] - The company's technology enables ultra-high data rates and secure long-distance data transmission, catering to both government and commercial satellite constellations [5]

Core Viewpoint - Mynaric is ramping up production and customer deliveries of its CONDOR Mk3 optical communications terminal while undergoing StaRUG proceedings for financial restructuring [1][7]. Production and Delivery - The company is committed to delivering scalable products that meet evolving program requirements and drive innovation in multi-orbit constellations [2]. - Mynaric is increasing deliveries of its flagship CONDOR Mk3 terminals [7]. Financial Restructuring - The StaRUG proceedings aim to provide significant debt relief, allowing Mynaric to serve current and potential customers effectively [2][5]. - Mynaric's lenders have agreed to a restructuring plan that includes a capital reduction to zero [5]. - A fourth bridge loan of USD 28 million and an additional USD 25 million restructuring loan have been committed to support ongoing operations and production plans [6][8]. Strategic Partnerships and Projects - Mynaric is involved in key projects such as the U.S. Space Development Agency's Proliferated Warfighter Space Architecture programs and DARPA's Space-BACN program [4]. - The company has been selected by the European Space Agency to investigate optical technologies for next-generation high-throughput optical inter-satellite links [4]. Future Outlook - The restructuring is viewed as a necessary step to create a fresh start for Mynaric, enabling investment in high-tech advancements and maintaining competitive pricing [6].

Core Viewpoint - Mynaric AG is facing a class action lawsuit due to alleged false and misleading statements regarding production delays and financial guidance, which may have negatively impacted investor confidence and the company's revenue growth [4]. Group 1: Class Action Details - The class action lawsuit pertains to Mynaric securities purchased between June 20, 2024, and October 7, 2024, with a lead plaintiff deadline set for December 30, 2024 [7]. - Investors who purchased Mynaric securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. Group 2: Allegations Against Mynaric - The lawsuit claims that Mynaric made false statements regarding production yields and component shortages, which led to production delays for its CONDOR Mk3 product [4]. - It is alleged that these issues would likely result in a material negative impact on the company's revenue growth and could lead to an operating loss [4]. - The company is accused of overstating its business and financial prospects, which misled investors [4].

Core Viewpoint - Mynaric AG is facing a class action lawsuit due to alleged false and misleading statements regarding production delays and financial guidance, which may have negatively impacted investors during the Class Period [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Mynaric's production delays were caused by lower-than-expected production yields and component supplier shortages for its CONDOR Mk3 product [2]. - These issues are expected to materially affect Mynaric's revenue growth and could lead to an operating loss [2]. - Mynaric is unlikely to meet its previously issued financial guidance for FY 2024, leading to overstated business and financial prospects [2]. Group 2: Class Action Participation - Investors who purchased Mynaric securities between June 20, 2024, and October 7, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][3]. - A lead plaintiff must be appointed by December 30, 2024, to represent other class members in the litigation [6]. - Investors can choose to remain absent from the class or select their own counsel, as no class has been certified yet [5]. Group 3: Rosen Law Firm's Role - The Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered significant amounts for investors, including over $438 million in 2019 [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Mynaric AG due to significant losses suffered by investors, particularly related to misleading statements and production issues affecting the company's financial performance [2][4]. Group 1: Legal Investigation and Claims - Faruqi & Faruqi is encouraging investors who incurred losses exceeding $50,000 in Mynaric between June 20, 2024, and October 7, 2024, to discuss their legal options [1]. - A federal securities class action has been filed against Mynaric, with a deadline of December 30, 2024, for investors to seek the role of lead plaintiff [2][10]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations Against Mynaric - The complaint alleges that Mynaric and its executives violated federal securities laws by making false or misleading statements regarding production yields and component shortages, which led to production delays for the CONDOR Mk3 product [4]. - Mynaric's updated guidance for FY 2024 indicates a significant reduction in expected revenue, now projected between EUR 16.0 million to EUR 24.0 million, down from EUR 50.0 million to EUR 70.0 million, due to production delays [5]. - The company also anticipates an operating loss for FY 2024 between EUR 55.0 million to EUR 50.0 million, compared to previous guidance of a loss between EUR 40.0 million to EUR 30.0 million [5]. Group 3: Stock Price Impact - Following the announcement of production delays and revised financial guidance, Mynaric's ADS price fell by $2.32, or 55.9%, closing at $1.83 on August 20, 2024 [5]. - After the termination of the CEO, the ADS price dropped by $0.11, or 9.73%, to close at $1.02 on August 27, 2024 [6][7]. - On October 8, 2024, Mynaric received a deficiency letter from Nasdaq regarding non-compliance with listing criteria, resulting in a further decline of $0.07, or 4.37%, to close at $1.53 [8][9].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Mynaric AG securities between June 20, 2024, and October 7, 2024, of the December 30, 2024, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Mynaric securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by December 30, 2024, to serve as lead plaintiff [2] - The lawsuit alleges that Mynaric made false and misleading statements regarding production delays and financial guidance, which negatively impacted investor expectations [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Viewpoint - Rosen Law Firm has announced the filing of a class action lawsuit on behalf of purchasers of Mynaric AG securities during the specified Class Period, highlighting potential compensation for affected investors [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between June 20, 2024, and October 7, 2024, and aims to address misleading statements made by Mynaric AG regarding its production and financial outlook [1][5]. - Investors who purchased Mynaric securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - Interested parties can join the class action by submitting a form or contacting the law firm directly, with a deadline for lead plaintiff applications set for December 30, 2024 [3][6]. Group 2: Allegations Against Mynaric AG - The lawsuit alleges that Mynaric AG made false and misleading statements regarding production yields and component shortages, which led to production delays for its CONDOR Mk3 product [5]. - It is claimed that these issues would negatively impact Mynaric's revenue growth and potentially lead to an operating loss, making it unlikely for the company to meet its previously issued financial guidance for FY 2024 [5]. - The lawsuit asserts that Mynaric's public statements were materially false and misleading, resulting in investor damages when the true situation became known [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its success in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [4].

Core Viewpoint - Mynaric AG is facing a class action lawsuit due to alleged false and misleading statements regarding its business operations and financial prospects during the specified class period from June 20, 2024, to October 7, 2024 [1][3]. Group 1: Class Action Details - Investors who purchased Mynaric securities during the class period can file a lead plaintiff motion by December 30, 2024 [1]. - The Portnoy Law Firm is offering a complimentary case evaluation for affected investors [2]. Group 2: Allegations Against Mynaric - The complaint alleges that Mynaric's management made false statements about production yields and supplier shortages, which caused delays in the production of the CONDOR Mk3 product [3]. - It is claimed that these undisclosed issues would negatively impact the company's revenue growth and potentially lead to an operating loss [3]. - The lawsuit asserts that Mynaric would likely not meet its previously issued financial guidance for FY 2024, and that the company's public statements were materially false and misleading throughout the class period [3].

Core Viewpoint - A class action has been filed against Mynaric AG for allegedly misleading investors about its business prospects, particularly regarding production delays and financial guidance for FY 2024 [2][3]. Group 1: Allegations and Impact - The complaint alleges that Mynaric failed to disclose production delays caused by lower-than-expected production yields and component supplier shortages, which negatively impacted revenue growth and led to an operating loss [2]. - Mynaric revised its FY 2024 revenue guidance from a range of EUR 50.0 million to EUR 70.0 million down to EUR 16.0 million to EUR 24.0 million, and its operating loss guidance from EUR 40.0 million to EUR 30.0 million up to EUR 55.0 million to EUR 50.0 million [3]. - Following the announcement of these issues, Mynaric's American Depository Share price fell by $2.32, or 55.9%, closing at $1.83 on August 20, 2024 [4]. Group 2: Legal Proceedings - Shareholders who wish to serve as lead plaintiffs in the class action must submit their applications by December 30, 2024 [5]. - Participation in the class action is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [5]. Group 3: Company Background - Mynaric AG specializes in developing and manufacturing laser communication products for aerospace-based communication networks, targeting both government and commercial markets [1].